The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostate-specific Antigen (PSA) Testing Market Research Report 2025
Synopsis
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK4 gene.
The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a la
The global Prostate-specific Antigen (PSA) Testing market was valued at US$ 511 million in 2023 and is anticipated to reach US$ 628.6 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 81% of the global market. CLIA is th
This report aims to provide a comprehensive presentation of the global market for Prostate-specific Antigen (PSA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate-specific Antigen (PSA) Testing.
Report Scope
The Prostate-specific Antigen (PSA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate-specific Antigen (PSA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate-specific Antigen (PSA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
Segment by Type
CLIA Method
ELISA Method
Segment by Application
Screening
Post-treatment Monitoring
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate-specific Antigen (PSA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK4 gene.
The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a la
The global Prostate-specific Antigen (PSA) Testing market was valued at US$ 511 million in 2023 and is anticipated to reach US$ 628.6 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 81% of the global market. CLIA is th
This report aims to provide a comprehensive presentation of the global market for Prostate-specific Antigen (PSA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate-specific Antigen (PSA) Testing.
Report Scope
The Prostate-specific Antigen (PSA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate-specific Antigen (PSA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate-specific Antigen (PSA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
Segment by Type
CLIA Method
ELISA Method
Segment by Application
Screening
Post-treatment Monitoring
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate-specific Antigen (PSA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CLIA Method
1.2.3 ELISA Method
1.3 Market by Application
1.3.1 Global Prostate-specific Antigen (PSA) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Screening
1.3.3 Post-treatment Monitoring
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate-specific Antigen (PSA) Testing Market Perspective (2019-2030)
2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Region
2.2.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Size by Region (2019-2024)
2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Region (2025-2030)
2.3 Prostate-specific Antigen (PSA) Testing Market Dynamics
2.3.1 Prostate-specific Antigen (PSA) Testing Industry Trends
2.3.2 Prostate-specific Antigen (PSA) Testing Market Drivers
2.3.3 Prostate-specific Antigen (PSA) Testing Market Challenges
2.3.4 Prostate-specific Antigen (PSA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue
3.1.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue (2019-2024)
3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
3.4 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
3.4.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2023
3.5 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
3.6 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
3.7 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate-specific Antigen (PSA) Testing Breakdown Data by Type
4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2019-2024)
4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2025-2030)
5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application
5.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Application (2019-2024)
5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
6.2 North America Prostate-specific Antigen (PSA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)
6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
7.2 Europe Prostate-specific Antigen (PSA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)
7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
8.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
9.2 Latin America Prostate-specific Antigen (PSA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)
9.4 Latin America Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size (2019-2030)
10.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
11.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Detail
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
11.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.2.5 Boston Scientific Corporation Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Detail
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
11.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.3.5 Bayer AG Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Detail
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
11.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.4.5 Siemens Healthcare Recent Development
11.5 DiaSorin
11.5.1 DiaSorin Company Detail
11.5.2 DiaSorin Business Overview
11.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
11.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.5.5 DiaSorin Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
11.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Detail
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
11.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.7.5 Beckman Coulter Recent Development
11.8 PerkinElmer
11.8.1 PerkinElmer Company Detail
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
11.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.8.5 PerkinElmer Recent Development
11.9 Tosoh
11.9.1 Tosoh Company Detail
11.9.2 Tosoh Business Overview
11.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
11.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.9.5 Tosoh Recent Development
11.10 Ortho Clinical
11.10.1 Ortho Clinical Company Detail
11.10.2 Ortho Clinical Business Overview
11.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
11.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.10.5 Ortho Clinical Recent Development
11.11 Fujirebio
11.11.1 Fujirebio Company Detail
11.11.2 Fujirebio Business Overview
11.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
11.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.11.5 Fujirebio Recent Development
11.12 Mediwatch
11.12.1 Mediwatch Company Detail
11.12.2 Mediwatch Business Overview
11.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
11.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.12.5 Mediwatch Recent Development
11.13 BodiTech
11.13.1 BodiTech Company Detail
11.13.2 BodiTech Business Overview
11.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
11.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.13.5 BodiTech Recent Development
11.14 Bristol-Myers Squibb Company
11.14.1 Bristol-Myers Squibb Company Company Detail
11.14.2 Bristol-Myers Squibb Company Business Overview
11.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
11.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.14.5 Bristol-Myers Squibb Company Recent Development
11.15 GE Healthcare
11.15.1 GE Healthcare Company Detail
11.15.2 GE Healthcare Business Overview
11.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
11.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.15.5 GE Healthcare Recent Development
11.16 Endocare
11.16.1 Endocare Company Detail
11.16.2 Endocare Business Overview
11.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
11.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.16.5 Endocare Recent Development
11.17 Merck＆Co.
11.17.1 Merck＆Co. Company Detail
11.17.2 Merck＆Co. Business Overview
11.17.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Introduction
11.17.4 Merck＆Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.17.5 Merck＆Co. Recent Development
11.18 Medtronic
11.18.1 Medtronic Company Detail
11.18.2 Medtronic Business Overview
11.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
11.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.18.5 Medtronic Recent Development
11.19 Sanofi-Aventis SA
11.19.1 Sanofi-Aventis SA Company Detail
11.19.2 Sanofi-Aventis SA Business Overview
11.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
11.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2019-2024)
11.19.5 Sanofi-Aventis SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
